Physician profile
Saibal Kar
NPI 1063449403
$1,106,034.28
in general payments reported to CMS, 2019-2025
49 companies · $53K in 2025
The $53K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $285K · 2020: $117K · 2021: $108K · 2022: $134K · 2023: $318K · 2024: $91K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $265K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $102K · Food and Beverage: $31K · Consulting Fee: $30K · Travel and Lodging: $25K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,813 · Grant: $958 · Long Term Medical Supply Or Device Loan: $282 · Other payment types: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $264,916.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $101,862.50 |
| Food and Beverage | $31,313.65 |
| Consulting Fee | $30,485.00 |
| Travel and Lodging | $24,957.01 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,812.50 |
| Grant | $957.52 |
| Long Term Medical Supply Or Device Loan | $281.66 |
| Other payment types | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $290,771.36 | 2019-2025 | Mitraclip, Triclip, Navitor |
| Ethicon INC. | $264,916.04 | 2023 | |
| Boston Scientific Corporation | $256,470.22 | 2019-2025 | Watchman Access System, Watchman Flx, Watchman |
| Medtronic, INC. | $215,538.51 | 2021-2025 | Corevalve Evolut R, Affera Mapping System, Apollotm |
| W. L. Gore & Associates, INC. | $37,893.52 | 2019-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder |
| Medtronic Vascular, INC. | $22,507.05 | 2019-2020 | |
| Edwards Lifesciences Corporation | $4,438.47 | 2019-2025 | Evoque, Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $2,366.10 | 2019-2025 | Impella |
| Siemens Medical Solutions USA, INC. | $1,481.26 | 2019-2024 | |
| Heartflow, INC. | $1,379.68 | 2022-2025 | Ffrct |
| Penumbra, INC. | $1,348.06 | 2021-2024 | Indigo System |
| Inari Medical, INC. | $1,035.74 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $790.06 | 2019-2025 | Repatha, Repatha |
| Biosense Webster, INC. | $783.10 | 2021-2025 | Carto 3, Nuvision Ice Catheter |
| Shockwave Medical, INC | $497.88 | 2022-2025 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $385.98 | 2023-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Cook Medical LLC | $371.38 | 2019-2021 | |
| Ge Healthcare | $350.95 | 2020-2024 | |
| Biotronik INC. | $339.69 | 2021-2025 | Amvia Edge, Biomonitor, Acticor 7 Vr-T Dx |
| Philips North America LLC | $278.89 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $194.58 | 2019-2024 | Leqvio |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $156.34 | 2023-2025 | Lifevest |
| Stryker Corporation | $150.95 | 2025 | Clottriever Bold Catheter |
| Irhythm Technologies, INC. | $147.27 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Alnylam Pharmaceuticals INC. | $132.01 | 2025 | Amvuttra |
| Cvrx, INC. | $130.60 | 2023 | Barostim Neo System |
| Cardiovascular Systems INC. | $123.58 | 2019-2021 | |
| Asahi Intecc USA, INC. | $118.75 | 2023 | Asahi Ptca Guide Wire |
| Merck Sharp & Dohme LLC | $99.89 | 2023 | Verquvo |
| Elutia, INC. | $91.86 | 2022 | |
| Zoll Circulation INC | $85.43 | 2022 | |
| Angiodynamics, INC. | $76.36 | 2023 | Auryon Laser System 100-120 Vac |
| Viz.Ai, INC. | $76.35 | 2021 | |
| Pfizer INC. | $71.10 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $61.78 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $60.99 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Becton, Dickinson and Company | $59.49 | 2025 | |
| Cordis US Corp. | $46.33 | 2024-2025 | Selution Slrpta, Selution Slr Ptca |
| Impulse Dynamics (USA) INC. | $37.62 | 2024 | Optimizer |
| United Therapeutics Corporation | $33.24 | 2024 | Tyvaso |
| Novo Nordisk INC | $24.95 | 2024 | Rybelsus, Ozempic |
| Amarin Pharma, INC. | $23.80 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.62 | 2019 | |
| Lemaitre Vascular, INC. | $22.80 | 2025 | Tyke, Patch, Pledget and Intracardiac |
| Janssen Pharmaceuticals, INC | $21.85 | 2019 | |
| Scpharmaceuticals INC. | $18.80 | 2024 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,000.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$8,787.50 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saibal Kar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.